Daneng Li, MD, Assistant Clinical Professor, Department of Medical Oncology & Therapeutics Research, Liver Program Disease Team Lead, City of Hope offers the next steps if a hepatocellular carcinoma (HCC) patient fails 1st line therapy.
Advertisement